"10.1371_journal.pone.0001135","plos one","2007-11-07T00:00:00Z","Bassim Al-Sakere; Franck Andr√©; Claire Bernat; Elisabeth Connault; Paule Opolon; Rafael V Davalos; Boris Rubinsky; Lluis M Mir","CNRS UMR 8121, Institut Gustave-Roussy, Villejuif, France; University Paris-Sud, UMR 8121, Villejuif, France; School of Biomedical Engineering and Sciences, Virginia Tech-Wake Forest University, Blacksburg, Virginia, United States of America; Department of Bioengineering, University of California at Berkeley, Berkeley, California, United States of America; Department of Mechanical Engineering and Graduate Program in Biophysics, University of California at Berkeley, Berkeley, California, United States of America; Center for Bioengineering in the Service of Humanity and Society, School of Computer Science and Engineering, Hebrew University of Jerusalem, Givat Ram, Jerusalem, Israel","Conceived and designed the experiments: BR LM RD. Performed the experiments: PO BA FA CB EC. Analyzed the data: PO BR LM BA FA RD. Contributed reagents/materials/analysis tools: PO. Wrote the paper: BR LM RD.","R. Davalos and B. Rubinsky have potential interests in the revenues of pending patents held by Univ. of California at Berkeley (e.g. No 10/571,162, Tissue Ablation with Irreversible Electroporation). B. Rubinsky also has a financial interest in Excellin Life Sciences and in Oncobionic, companies in the field of electroporation. L. M. Mir was a consultant for Oncobionics.","2007","11","Bassim Al-Sakere","BAS",8,TRUE,3,5,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
